Search
Close this search box.

A Prospective, Non-Randomised Study of Chemotherapy and Radiotherapy for Osteolymphoma (OL)

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Related Post

24 October, 2024

Promising new results from RAIDER trial published

24 October 2024: Newly published findings from the TROG

23 October, 2024

New Cancer Australia grant supports TROG work

23 October 2024: TROG Cancer Research is thrilled to